Clinical Evidence
Successful Utilization of a Computer-Guided Glucose Management System for a Surgical Care Improvement Project at a Tertiary Care Hospital
Setting: 950-bed tertiary care teaching hospital
Objective
This surgical care improvement project examines the correlation between utilization of a computer-guided glucose management system (EndoTool) and outcomes of national quality initiatives.
Setting
950-bed tertiary care teaching hospital.
Results
- Over a period of four years and 8,078 patients, average time to target blood glucose was 3.38 hours for 180 mg/dL, 3.99 hours for 160 mg/dL, 4.51 hours for 150 mg/dL and 5.35 hours for 140 mg/dL.
- Over a period of four years and and 260,870 blood glucose readings, incidence of hypoglycemia <40 mg/dL was 0.02% and <70 mg/dL was 0.86%.
- Rate of hospital-acquired conditions per 1,000 under HAC-8 (manifestations of poor glycemic control) decreased 61%, from 0.083 pre-EndoTool utilization to 0.032 post-EndoTool utilization, and was sustained at 45% lower than the national average of 0.058.
- Rate of SCIP-Inf-4 compliance (glucose control for cardiac surgery patients) increased 12.5%, from 88% pre-EndoTool utilization to 99% post-EndoTool utilization.
Conclusions
Performance under the HAC-8 and SCIP-Inf-4 measures improve demonstrably in conjunction with use of a computer-guided glucose management system (EndoTool), representing a doubling in cost savings, with outcomes in the top tier of all hospitals nationwide.
References
Authors
Robert Tanenberg, MD; Sandra Hardee, PharmD; Herbert Garrison, MD; Joseph Elbeery, MD.
Source
Presented at American Diabetes Association Scientific Sessions.
Year
2013
Related posts

Clinical Evidence
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).

Clinical Evidence
How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M
How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M
The objective of this study was to evaluate the impact of EndoTool IV insulin dosing software on mortality, length of stay, readmission rates, and cost of care for patients treated for Diabetic Ketoacidosis (DKA) at Corewell Health West.

Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields